Anna L Hoppmann
Overview
Explore the profile of Anna L Hoppmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoppmann A, Dai C, Hageman L, Francisco L, Knight J, Mast A, et al.
J Cancer Surviv
. 2024 Aug;
PMID: 39107579
Purpose: Childhood cancer survivors carry a high burden of late-occurring treatment-related morbidity. Long-term risk-based anticipatory surveillance allows for early detection and management of complications. We sought to examine demographic, clinical,...
2.
Erker C, Mynarek M, Bailey S, Mazewski C, Baroni L, Massimino M, et al.
J Clin Oncol
. 2022 Dec;
41(10):1921-1932.
PMID: 36548930
Purpose: Infant and young childhood medulloblastoma (iMB) is usually treated without craniospinal irradiation (CSI) to avoid neurocognitive late effects. Unfortunately, many children relapse. The purpose of this study was to...
3.
Wadhwa A, Chen Y, Hageman L, Hoppmann A, Angiolillo A, Dickens D, et al.
Cancer
. 2022 Nov;
129(1):151-160.
PMID: 36369905
Background: Obesity at diagnosis of childhood acute lymphoblastic leukemia (ALL) is associated with greater risk of relapse; whether this association extends to obesity during maintenance is unstudied. Methods: This study...
4.
Hoppmann A, Dai C, Daves M, Imran H, Whelan K, Kenzik K, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Sep;
32(3):380-386.
PMID: 36129811
Background: One-fifth of U.S. counties are designated persistent child poverty counties (≥20% of children in poverty since 1980). The association between a persistent child poverty environment and mortality in children...
5.
Hoppmann A, Chen Y, Landier W, Hageman L, Evans W, Wong F, et al.
Cancer
. 2021 Jun;
127(20):3832-3839.
PMID: 34161608
Background: Poor mercaptopurine (6MP) adherence (mean adherence rate < 90%) increases the relapse risk among children with acute lymphoblastic leukemia (ALL). 6MP adherence remains difficult to measure in real time....